# Teicoplanin in Treating Septicemia in Patients Who Are Receiving Chemotherapy Through a Central Venous Catheter

> **NCT00024453** · NA · UNKNOWN · sponsor: **Children's Cancer and Leukaemia Group** · enrollment: 1360 (estimated)

## Conditions studied

- Infection

## Interventions

- **BIOLOGICAL:** teicoplanin

## Key facts

- **NCT ID:** NCT00024453
- **Lead sponsor:** Children's Cancer and Leukaemia Group
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-02
- **Primary completion:** 2009-12
- **Final completion:** —
- **Target enrollment:** 1360 (ESTIMATED)
- **Last updated:** 2013-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00024453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00024453, "Teicoplanin in Treating Septicemia in Patients Who Are Receiving Chemotherapy Through a Central Venous Catheter". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00024453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*